NAMS
NewAmsterdam Pharma Company N.V.
22.80$
-1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 99.9% | 99.9% | 99.7% | 99.7% | 99.9% | 99.9% | 94.4% | 93.1% | 87.8% | 89.8% | 93.6% | |
| – | 98.1% | 98.5% | 96.4% | 96.3% | 89.3% | 91.4% | 69.2% | 68.5% | 63.7% | 62.5% | 60.2% | |
| – | 98.1% | 98.5% | 96.4% | 96.3% | 96.5% | 98.8% | 90.7% | 89.4% | 82.7% | 86.8% | 90.0% | |
| – | 0.5% | 0.8% | 1.1% | 1.2% | 2.5% | 0.2% | 2.4% | 2.6% | 3.0% | 1.1% | 3.4% | |
| – | -0.5% | 0.0% | -1.1% | -1.2% | – | – | – | – | – | – | – | |
| – | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | |
| – | 16.9% | 15.7% | 13.3% | 13.7% | 12.4% | 5.0% | 4.5% | 7.4% | 11.2% | 9.2% | 10.4% | |
| – | 14.4% | 12.2% | 10.1% | 9.4% | 12.4% | 5.0% | 4.5% | 7.4% | 11.2% | 9.2% | 10.4% | |
| – | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | 4.9% | 1.7% | 1.2% | 1.6% | 0.5% | 0.7% | 0.7% | 0.5% | 1.2% | 1.1% | 0.8% | |
| – | 83.1% | 84.3% | 86.7% | 86.3% | 87.6% | 95.0% | 95.5% | 92.6% | 88.8% | 90.8% | 89.6% | |
| – | -91.3% | -84.1% | -100.7% | -106.2% | -64.6% | -73.1% | -75.5% | -87.4% | -99.1% | -110.7% | -124.2% | |
| – | 23.8% | 18.1% | 21.2% | 21.6% | 11.2% | 14.2% | 13.8% | 15.1% | 14.9% | 16.5% | 17.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.